5 CONCLUSION
G allele of VEGF-634 G>C polymorphism was
associated with moderate + severe neutrophil
infiltration
ACKNOWLEDGEMENT
The authors would like to thank for the funding
support by Research Institute, Universitas
Sumatera Utara (Contract number :
59/UN5.2.3.1/PPM-KP-TALENTAUSU/2018)
REFERENCES
Angelo, L., Kurzrock, R., 2007. Vascular endothelial
growth factor and its relationship to inflammatory
mediators. Clin Cancer Res. 13:2825-30.
Atayan, Y., Hacisalihoglu, P., 2017. The Correlation
Between Tissue Helicobacter Pylori Severity and
the Increase in Serum Neutrophil/Lymphocyte
Ratio in Patients with Active Chronic Gastritis.
Biomed Res. 28:4874 - 7.
Caputo, R., Tuccillo, C., Manzo, B., Zarrilli, R.,
Tortora, G., Blanci, C., et al., 2003. Helicobater
pylori VacA Toxin Up-Regulates Vascular
Endothelial Growth Factor Expression in MKN 28
Gastric Cells through an Epidermal Growth Factor
receptor-, Cyclooxygenase-2-dependent
Mechanism. Clin Cancer Res. 9:2015-21.
Corvalan, A., Carrasco, G., Saavedra, K., 2012. The
genetic and epigenetic bases of gastritis. In Current
Topics in Gastritis, InTech. London. p.79-95.
Dhakwa, R., Acharya, I., Shrestha, H., Joshi, D., 2012.
Lama S and Lakhey M. Histopathologic Study of
Chronic Antral Gastritis. Nepal Health Res Counc.
10:57-60.
Eng, L., Azad, A., Habbous, S., Pang, V., Xu, W.,
Maitland-van der Zee, A., et al., 2012. Vascular
endothelial growth factor pathway polymorphisms
as prognostic and pharmacogenetic factors in
cancer: a systematic review and meta-analysis. Clin
Cancer Res. 18:4526-537.
Eng, L., Liu, G., 2013. VEGF pathway polymorphisms
as prognostic and pharmacogenetics factors in
cancer: a 2013 update. Pharmacogenomics.
14:1659-67.
Ghanaei, F., Sanaei, O., Joukar, F., 2011. Clinical
Validation of an Office-Based 14C-UBT
(Heliprobe) for H. pylori Diagnosis in Iranian
Dyspeptic Patients. Gastroenterol Res Pract. 2011:
930941.
Kang, M., Song, E., Kim, B., Kim, D., Park, J., 2014.
Helicobacter pylori induces vascular endothelial
growth factor production in gastric epithelial cells
through hypoxia-inducible factor-1α dependent
pathway. Helicobacter. 19:476-83.
Lee, S., Jeong, D., Han, Y., Baek, M., 2015. Pivotal
role of vascular endothelial growth factor pathway
in tumor angiogenesis. Ann Surg Treat Res. 89:1-8.
Logsdon, E., Finley, S., Popel, A., Gabhann, F., 2014.
A systems biology view of blood vessel growth and
remodelling. J Cell Mol Med. 18:1491-508.
Oh, S., Kwon, H., Kim, S., Lee, S., Lee, J., Hwang, J.,
2013. The Relationship of Vascular Endothelial
Growth Factor Gene Polymorphisms and Clinical
Outcome in Advanced Gastric Cancer Patients
treated with FOLFOX: VEGF Polymorphism in
Gastric Cancer. BMC Cancer. 13:43.
Rojborwonwitaya, J., Vijitjunykul, N., 2005.
Comparison of the Accuracy of Two Commercial
Rapid Urase Tests, CLOtest®, and Pronto Dry®, in
detecting Helicobacter pylori Infection. Thai J
Gastroenterol. 6:55-60.
Rugge, M., Pennelli, G., Pilozzi, E., Fassan, M.,
Ingravallo, G., Russo, V., et al., 2011. Gastritis: the
histology report.
Dig Liver Dis. 43S:S373–84.
Shaik-Dasthagirisaheb, Y., Varvara, G., Murmura, G.,
Saggini, A., Potalivo, G., Caraffa, A., et al., 2013.
Vascular endothelial growth factor (VEGF), mast
cells, and inflammation. Int J Immunopathol
Pharmacol. 26:327-35.
Sinnathamby, T., Yun, J., Clavet-Lanthier, M., Cheong,
C., Sirois, M., 2015. VEGF and angiopoietins
promote inflammatory cell recruitment and mature
blood vessel formation in urine sponge/ Matrigel
model. J Cell Biochem. 116:45-57.
Siregar, G., Sari, D., Sungkar, T., 2017. Serum VEFG
level in Helicobacter pylori infection and
correlation with Helicobacter pylori cagA and vacA
genes. Open Access Maced J Med Sci. 5:137-41.
Tuccillo, C., Cuomo, A., Rocco, A., Martinelli, E.,
Staibano, S., Mascolo, M., 2005. Vascular
endothelial growth factor and neo-angiogenesis in
H. pylori gastritis in humans. J Pathol. 207:277-84.
Association between VEGF-634G>C Gene Polymorphism with Degree of Neutrophil and Lymphocyte Infiltration in Helicobacter pylori